993082

Vertical Pharmaceuticals, LLC — FEI 3004421212

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 1, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Sayreville, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
672821 CFR 314.80(b)Failure to review ADE information
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683021 CFR 314.80(c)(2)Interval
891221 CFR 314.81(b)(2)Timely submission